111 (YI) Receivables - Other (2018 - 2019)
111 (YI) reported Receivables - Other of $86831.0 for Q4 2019, up 282.4% on a YoY basis from $22706.8 in Q4 2018, and up 282.4% sequentially from $22706.8 in Q4 2018.
111 (YI) Receivables - Other (2018 - 2019) Analysis & Trends
111 (YI) has 2 years of Receivables - Other data on file, last reported at $86831.0 in Q4 2019.
- For the quarter ending Q4 2019, Receivables - Other rose 282.4% year-over-year to $86831.0; the trailing twelve-month figure through Dec 2019 stood at $86831.0 (up 282.4% YoY), and the FY2019 full-year result was $88634.7, down 72.44% from the prior year.
- Receivables - Other improved to $86831.0 in Q4 2019, from $22706.8 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $86831.0 in Q4 2019 to a low of $22706.8 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2018 | 22,706.85 |
| Dec 31, 2018 | 22,706.85 |